Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Midkine inhibits dormancy of disseminated melanoma cells.

bioRxiv : the preprint server for biology·2025
Same author

Interleukin 4 Controls the Pro-Tumoral Role of Macrophages in Mammary Cancer Pulmonary Metastasis in Mice.

Cancers·2022
Same author

NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.

Cancer research·2022
Same author

An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy.

The Journal of experimental medicine·2021
Same author

Understanding the mechanistic features of cancer metastasis.

Cancer reports (Hoboken, N.J.)·2020
Same journal

Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysis.

Clinical & experimental metastasis·2026
Same journal

NF1 mutation may be associated with lung-tropic metastasis in cutaneous melanoma: a genomic analysis of 520 patients.

Clinical & experimental metastasis·2026
Same journal

Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation.

Clinical & experimental metastasis·2026
Same journal

Mechanisms of breast cancer dormancy in bone metastasis.

Clinical & experimental metastasis·2026
Same journal

Editorial Expression of Concern: Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC.

Clinical & experimental metastasis·2026
Same journal

Local control and dose selection for lung cancer brain metastases treated with radiosurgery: an artificial intelligence model.

Clinical & experimental metastasis·2026
查看所有相关文章

相关实验视频

Updated: Jun 30, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

我们对转移过程了解多少?

Carolina Rodriguez-Tirado1,2,3,4,5, Maria Soledad Sosa6,7,8,9,10

  • 1Department of Microbiology and Immunology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, 10461, USA. carolina.rodriguez@einsteinmed.edu.

Clinical & experimental metastasis
|March 23, 2024
PubMed
概括
此摘要是机器生成的。

散播癌细胞 (DCC) 可以保持休眠状态,逃避当前的治疗方法. 新的策略旨在准这些最小的残留疾病细胞,以防止转移并改善患者的生存率.

关键词:
扩散的癌细胞传播.休眠状态是一个休眠状态.在EMT中,EMT是EMT.早期传播 早期传播转移 转移 转移 转移

更多相关视频

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.5K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.0K

相关实验视频

Last Updated: Jun 30, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.5K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.0K

科学领域:

  • 在瘤学瘤学.
  • 癌症生物学 癌症生物学
  • 转移研究 转移研究

背景情况:

  • 散播癌细胞 (DCCs) 可以早期扩散并进入休眠状态.
  • 休眠的DCC逃避了针对初级瘤的当前疗法.
  • 检测DCC与患者的生存率低下有关.

研究的目的:

  • 审查目前用于检测DCC的方法.
  • 突出针对休眠DCC作为最小残留疾病的新策略.
  • 讨论DCC在早期转移和传播机制中的作用.

主要方法:

  • 对DCC检测和准现有文献的审查.
  • 对早期DCCs临床相关性的证据分析.
  • 讨论用于研究DCCs的动物模型.
  • 在癌细胞扩散中探索上皮层-介质细胞过渡 (EMT).

主要成果:

  • DCCs可以在休眠状态下持续存在,这对当前的治疗方法构成了挑战.
  • 向休眠的DCC对于预防转移和减少最小残留疾病至关重要.
  • 了解传播机制,包括EMT,是开发新疗法的关键.

结论:

  • 目前的治疗方法不足以消除休眠的DCC.
  • 需要新的治疗策略来准DCC并防止转移性复发.
  • 进一步研究DCC生物学及其与瘤微环境的相互作用是必不可少的.